Skip to content
Clinical Trials – home
SwedenBack to Sweden

Clinical trials in Koping – page 2

41 clinical trials in Koping, Sweden. Every trial is listed in the EU Clinical Trials Register and updated daily.

SwedenOur site in SwedenKliniska-Provningar.se(opens in a new tab)
Koping at a glance
41
clinical trials
  • Research sites0
Type of trial
Recruitment status
Quick filters

41 trials in Koping

Open in trial search

Study Comparing Benzylpenicillin and Cloxacillin for Treating Staphylococcus Aureus Blood Infection in Patients

Registered drugNo placebo
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Cloxacillin
  • Sponsor:Region Skane

Glioblastoma

Recruiting

Study on Lomustine and Temozolomide for Newly Diagnosed Glioblastoma Patients

Registered drugNo placebo
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Temozolomide
  • Sponsor:Region Oestergoetland

Breast cancer

Recruiting

Study on Extended Endocrine Therapy for High-Risk Breast Cancer Patients Using Tamoxifen, Exemestane, Anastrozole, and Letrozole

Registered drugNo placebo
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Anastrozole
  • Sponsor:Region Oerebro Laen

Induced labour+1

Recruiting

Study on Misoprostol for Inducing Labor in Pregnant Women: Comparing Outpatient and Inpatient Settings

Registered drugNo placebo
Countries:SwedenSweden
  • Participants:18–64 years
  • Substances:Misoprostol
  • Sponsor:University Of Gothenburg

Crohn's disease

Recruiting

Study on Crohn's Disease: Evaluating Risankizumab's Effects in Children Aged 2 to 17 with Moderate to Severe Symptoms

Investigational
Countries:SwedenSweden
  • Participants:0–17 years
  • Substances:Risankizumab
  • Sponsor:AbbVie Deutschland GmbH & Co. KG

Study on Apixaban for Preventing Stroke in Patients with Atrial Fibrillation and Stage 5 Chronic Kidney Disease

Registered drugNo placebo
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Apixaban
  • Sponsor:Karolinska University Hospital

Study Comparing Trastuzumab Deruxtecan with Standard Treatment for Patients with HER2-positive Breast Cancer

Registered drugNo placebo
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Aprepitant
  • Sponsor:Karolinska University Hospital

Study on the Effect of Rifampicin and Drug Combination for Patients with Staphylococcus aureus Bacteremia

Registered drugNo placebo
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Amoxicillin
  • Sponsor:Universitair Medisch Centrum Utrecht

Study on Short vs. Long Immunotherapy with Pembrolizumab and Nivolumab for Patients with High-Risk Skin Melanoma After Surgery

Registered drugNo placebo
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Nivolumab
  • Sponsor:North Estonia Medical Centre Foundation

Study of Pivmecillinam and Amoxicillin/Clavulanic Acid for Treating Urinary Tract Infections in Patients with Multidrug-Resistant Bacteria

Registered drugNo placebo
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Amoxicillin
  • Sponsor:Region Skane

Atrial fibrillation

Not yet recruiting

Prevention of Stroke and Systemic Embolism in Atrial Fibrillation Patients Treated with REGN7508 (cenvacibart) versus Apixaban

Registered drug
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Apixaban
  • Sponsor:Regeneron Pharmaceuticals Inc.

Analgesic therapy

Not yet recruiting

Comparing spinal morphine and epidural drug combination for pain relief in patients having open colorectal surgery

Registered drugNo placebo
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Fentanyl Citrate

Other cities in Sweden

The busiest research cities in the country

All 66 cities in Sweden

Clinical research in Koping

What the registry says about research in the country

01 Cardiovascular Research

Innovative clinical trials focusing on heart failure with preserved ejection fraction (HFpEF), exploring new therapeutic approaches for this challenging cardiovascular condition.

  • Treatment Optimization Studies
  • Cardiovascular Outcomes Research
  • Heart Failure Management

These studies aim to evaluate the effectiveness of standard treatments combined with specific medications to reduce hospitalizations and improve cardiovascular outcomes in patients with preserved ejection fraction heart failure.

02 Clinical Registry Research

Implementation of Registry-based Randomized Clinical Trials (RRCT) methodology to advance understanding of cardiovascular therapies and their real-world impact.

  • Pragmatic Trial Design
  • Treatment Comparison Studies
  • Clinical Outcomes Assessment

This research framework combines the rigor of randomized trials with the practical advantages of registry-based data collection to evaluate treatment effectiveness.

03 Therapeutic Interventions

Investigation of medication combinations and their impact on cardiovascular health, focusing on reducing hospitalization rates and improving patient outcomes.

  • Drug Efficacy Studies
  • Standard of Care Enhancement
  • Prevention Strategies

These trials examine how different therapeutic approaches can be optimized to better manage heart failure and reduce cardiovascular mortality.

Clinical Trials Concierge

Prefer not to search on your own, or looking for clinical trials for a rare disease?

Tell us about your condition – we search every trial in Europe and connect you with the right site.